Search

Your search keyword '"Moss Paul"' showing total 724 results

Search Constraints

Start Over You searched for: Author "Moss Paul" Remove constraint Author: "Moss Paul" Language english Remove constraint Language: english
724 results on '"Moss Paul"'

Search Results

1. Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19

4. Association between antibody responses post-vaccination and severe COVID-19 outcomes in Scotland

6. Accelerated immune ageing is associated with COVID-19 disease severity

8. Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study

9. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

10. Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial

12. Immunological imprinting of humoral immunity to SARS-CoV-2 in children

17. CMV and Immunosenescence: from basics to clinics

18. Analysis of ZAP70 expression in adult acute lymphoblastic leukaemia by real time quantitative PCR

19. Report from the second cytomegalovirus and immunosenescence workshop

20. Immunosenescence and Cytomegalovirus: where do we stand after a decade?

21. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national outbreak response

22. Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes

24. Ageing is associated with a decline in peripheral blood CD56bright NK cells

25. Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis

26. Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection

27. Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection

34. Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

35. Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia

37. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection

39. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

40. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

45. Corrigendum to ‘Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study’ [The Lancet Regional Health – Europe 35 (2023) 100747]

47. Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma.

50. USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status

Catalog

Books, media, physical & digital resources